<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12">
 <label>12.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Colarusso</surname>
    <given-names>C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Terlizzi</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Molino</surname>
    <given-names>A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Imitazione</surname>
    <given-names>P.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Somma</surname>
    <given-names>P.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rega</surname>
    <given-names>R.</given-names>
   </name>
   <etal>et al</etal>.
  </person-group> (
  <year>2019</year>) 
  <article-title>AIM2 Inflammasome Activation Leads to IL-1α and TGF-β Release From Exacerbated Chronic Obstructive Pulmonary Disease-Derived Peripheral Blood Mononuclear Cells</article-title>. 
  <source>Front. Pharmacol.</source>
  <volume>10</volume>, 
  <fpage>257</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2019.00257</pub-id>
  <?supplied-pmid 30930781?>
  <pub-id pub-id-type="pmid">30930781</pub-id>
 </mixed-citation>
</ref>
